Vericel to Present at the BIO CEO & Investor Conference
February 05 2018 - 8:00AM
Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell
therapies for the sports medicine and severe burn care markets,
today announced that Nick Colangelo, president and CEO, will
present the latest company overview at the BIO CEO & Investor
Conference in New York, NY on Monday, February 12, 2018 at 3:00pm
Eastern time.
The presentation will be webcast live at:
http://www.veracast.com/webcasts/bio/ceoinvestor2018/58210583112.cfm,
and may be accessed from the news and events section of the Vericel
website.
About Vericel CorporationVericel
develops, manufactures, and markets expanded autologous cell
therapies for the treatment of patients with serious diseases and
conditions. The company markets two cell therapy products in the
United States. Vericel is marketing MACI® (autologous cultured
chondrocytes on porcine collagen membrane), an autologous
cellularized scaffold product indicated for the repair of
symptomatic, single or multiple full-thickness cartilage defects of
the knee with or without bone involvement in adults. Vericel is
also marketing Epicel® (cultured epidermal autografts), a permanent
skin replacement for the treatment of patients with deep dermal or
full thickness burns greater than or equal to 30% of total body
surface area. For more information, please visit the company's
website at www.vcel.com.
Epicel® and MACI® are registered trademarks of
Vericel Corporation. © 2018 Vericel Corporation. All rights
reserved.
Global Media Contacts:David
SchullRusso Partners LLC+1 212-845-4271 (office)+1 858-717-2310
(mobile)David.schull@russopartnersllc.com
Karen ChaseRusso Partners LLC+1 646-942-5627
(office)+1 917-547-0434
(mobile)Karen.chase@russopartnersllc.com
Investor Contacts:Chad RubinThe
Trout Groupcrubin@troutgroup.com +1 (646) 378-2947
Lee SternThe Trout
Grouplstern@troutgroup.com +1 (646) 378-2922
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Sep 2023 to Sep 2024